Nextpower Inc. (NASDAQ:NXT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-eight research firms that are currently covering the stock, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, twenty-three have assigned a buy rating and one has issued a strong buy rating on the […]

Shares of BlossomHill Therapeutics, Inc. (NASDAQ:BLSM – Get Free Report) have been given an average rating of “Moderate Buy” by the six research firms that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) has received an average recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1-year target price […]

CVRx, Inc. (NASDAQ:CVRX – Get Free Report) has received a consensus rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have issued a buy recommendation on the company. The average 1-year […]

Shares of PBF Energy Inc. (NYSE:PBF – Get Free Report) have received a consensus rating of “Hold” from the fifteen ratings firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation, three have assigned a buy recommendation and one has assigned […]

Texas Roadhouse, Inc. (NASDAQ:TXRH – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twenty-three brokerages that are covering the company, MarketBeat reports. Twelve research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the […]

Alterity Therapeutics Limited – Sponsored ADR (NASDAQ:ATHE – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and five have given […]

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price […]

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has been given an average recommendation of “Hold” by the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and four have given a buy recommendation to […]

Shares of Gevo, Inc. (NASDAQ:GEVO – Get Free Report) have been given a consensus recommendation of “Hold” by the six ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on […]

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have received a consensus rating of “Buy” from the six research firms that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have covered the stock […]